{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:37:01Z","timestamp":1786243021764,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20913-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:58:25Z","timestamp":1761127105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endothelial soluble guanylate cyclase enzyme inhibitors as a novel target for the treatment of sepsis-related hypotension"],"prefix":"10.1038","volume":"15","author":[{"given":"Yousif Ali Ahmed","family":"Suleiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abuzor Mohamed Mohyeldin","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassir A.","family":"Almofti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20913_CR1","doi-asserted-by":"publisher","first-page":"1415274","DOI":"10.3389\/fmicb.2024.1415274","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis. Front. Microbiol. 15, 1415274 (2024).","journal-title":"Front. Microbiol."},{"issue":"3","key":"20913_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes, A. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit. Care Med. 45(3), 486\u2013552 (2017).","journal-title":"Crit. Care Med."},{"issue":"23","key":"20913_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"D Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. Storm June CH. Cytokine N. Engl. J. Med. 383(23), 2255\u20132273 (2020).","journal-title":"Cytokine N. Engl. J. Med."},{"issue":"16","key":"20913_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin, G. S., Mannino, D. M., Eaton, S. & Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348(16), 1546\u20131554 (2003).","journal-title":"N. Engl. J. Med."},{"key":"20913_CR5","unstructured":"Organization WH. WHO calls for global action on sepsis-cause of 1 in 5 deaths worldwide. (2020)."},{"issue":"9","key":"20913_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & Van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 369(9), 840\u2013851 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"8782\u20138783","key":"20913_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/0140-6736(91)92376-D","volume":"338","author":"A Petros","year":"1991","unstructured":"Petros, A., Bennett, D. & Vallance, P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338(8782\u20138783), 1557\u20131558 (1991).","journal-title":"Lancet"},{"issue":"8","key":"20913_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour, C. W. et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 762\u2013774 (2016).","journal-title":"JAMA"},{"issue":"8","key":"20913_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"4","key":"20913_CR10","doi-asserted-by":"publisher","first-page":"H1038","DOI":"10.1152\/ajpheart.1990.259.4.H1038","volume":"259","author":"G Julou-Schaeffer","year":"1990","unstructured":"Julou-Schaeffer, G. et al. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. Heart Circ. Physiol. 259(4), H1038\u2013H1043 (1990).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"20913_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/0006-291X(90)91565-A","volume":"172","author":"RG Kilbourn","year":"1990","unstructured":"Kilbourn, R. G. et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172(3), 1132\u20131138 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"20913_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0006-291X(05)80068-3","volume":"173","author":"D Rees","year":"1990","unstructured":"Rees, D., Cellek, S., Palmer, R. & Moncada, S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173(2), 541\u2013547 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"20913_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang, D., Kang, R., Coyne, C. B., Zeh, H. J. & Lotze, M. T. PAMP s and DAMP s: Signal 0s that spur autophagy and immunity. Immunol. Rev. 249(1), 158\u2013175 (2012).","journal-title":"Immunol. Rev."},{"issue":"1","key":"20913_CR14","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-021-25617-0","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu, R., Kang, Y. & Chen, L. Activation mechanism of human soluble guanylate cyclase by stimulators and activators. Nat. Commun. 12(1), 5492 (2021).","journal-title":"Nat. Commun."},{"issue":"5","key":"20913_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah, C., Michel, L. Y. & Balligand, J.-L. Nitric oxide signalling in cardiovascular health and disease. Nat. Rev. Cardiol. 15(5), 292\u2013316 (2018).","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"20913_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1515\/hsz-2018-0155","volume":"399","author":"P Sandner","year":"2018","unstructured":"Sandner, P. From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators. Biol. Chem. 399(7), 679\u2013690 (2018).","journal-title":"Biol. Chem."},{"issue":"3","key":"20913_CR17","doi-asserted-by":"publisher","first-page":"P24","DOI":"10.1186\/cc7826","volume":"13","author":"PG Czaikoski","year":"2009","unstructured":"Czaikoski, P. G., Nascimento, D. B. C., Spiller, F. & Cunha, F. Q. Heme oxygenase and soluble guanylate cyclase mediate the neutrophil migration failure to the lung in severe sepsis induced by pneumonia. Crit. Care 13(3), P24 (2009).","journal-title":"Crit. Care"},{"issue":"3","key":"20913_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1124\/jpet.108.142034","volume":"328","author":"D Fernandes","year":"2009","unstructured":"Fernandes, D. et al. Late, but Not Early, Inhibition of Soluble Guanylate Cyclase Decreases Mortality in a Rat Sepsis Model. J. Pharmacol. Exp. Ther. 328(3), 991\u2013999 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"20913_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1074-7613(00)00022-4","volume":"13","author":"A Cauwels","year":"2000","unstructured":"Cauwels, A. et al. Protection against TNF-Induced Lethal Shock by Soluble Guanylate Cyclase Inhibition Requires Functional Inducible Nitric Oxide Synthase. Immunity 13(2), 223\u2013231 (2000).","journal-title":"Immunity"},{"issue":"1","key":"20913_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15422119.2020.1797792","volume":"51","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Hypericin: Source, Determination, Separation, and Properties. Sep. Purif. Rev. 51(1), 1\u201310 (2022).","journal-title":"Sep. Purif. Rev."},{"issue":"11","key":"20913_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/fermentation10110559","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Advancements and Future Prospects in Hypocrellins Production and Modification for Photodynamic Therapy. Fermentation. 10(11), 559 (2024).","journal-title":"Fermentation."},{"issue":"2","key":"20913_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/j.2040-4603.2021.tb00154.x","volume":"11","author":"M Pecchiari","year":"2021","unstructured":"Pecchiari, M. et al. Cardiovascular responses during sepsis. Compr. Physiol. 11(2), 1605\u20131652 (2021).","journal-title":"Compr. Physiol."},{"issue":"2","key":"20913_CR23","first-page":"139","volume":"11","author":"A Kimmoun","year":"2013","unstructured":"Kimmoun, A., Ducrocq, N. & Levy, B. Mechanisms of vascular hyporesponsiveness in septic shock. Curr. Vasc. Pharmacol. 11(2), 139\u2013149 (2013).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"9","key":"20913_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/life14091085","volume":"14","author":"A Alamami","year":"2024","unstructured":"Alamami, A. et al. Clinical Outcomes of Angiotensin II Therapy in Vasoplegic Shock: A Systematic Review and Meta-Analysis. Life. 14(9), 1085 (2024).","journal-title":"Life."},{"key":"20913_CR25","unstructured":"Petrova O.\u00a0Regulation, activation, and deactivation of soluble guanylate cyclase and NO-sensors\u00a0(Doctoral dissertation, Universit\u00e9 Paris Saclay (COmUE))."},{"issue":"8","key":"20913_CR26","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/molecules26082383","volume":"26","author":"N Forouzesh","year":"2021","unstructured":"Forouzesh, N. & Mishra, N. An effective MM\/GBSA protocol for absolute binding free energy calculations: A case study on SARS-CoV-2 spike protein and the human ACE2 receptor. Molecules 26(8), 2383 (2021).","journal-title":"Molecules"},{"key":"20913_CR27","unstructured":"Mini\u0107, S., Annigh\u00f6fer, B., Br\u00fblet, A., Combet, S. Stability of food proteins at high pressure conditions. InSerbian Biochem. Soc. Twelfth Conf. 59 (2023)."},{"issue":"10","key":"20913_CR28","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/1573406419666230601092358","volume":"19","author":"CP da Silva","year":"2023","unstructured":"da Silva, C. P., das Neves, G. M., Poser, G. L., Eifler-Lima, V. L. & Rates, S. M. In silico prediction of ADMET\/drug-likeness properties of bioactive phloroglucinols from Hypericum genus. Med. Chem. 19(10), 1002\u20131017 (2023).","journal-title":"Med. Chem."},{"issue":"1","key":"20913_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0022-3565(24)39043-3","volume":"294","author":"RS Obach","year":"2000","unstructured":"Obach, R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John\u2019s Wort an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther. 294(1), 88\u201395 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"20913_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2125.2002.01683.x","volume":"54","author":"L Henderson","year":"2002","unstructured":"Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B. & Arlett, P. St John\u2019s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 54(4), 349\u2013356 (2002).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"20913_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1124\/dmd.32.5.512","volume":"32","author":"BJ Komoroski","year":"2004","unstructured":"Komoroski, B. J. et al. Induction and inhibition of cytochromes P450 by the St. John\u2019s wort constituent hyperforin in human hepatocyte cultures. Drug Metabol. Dispos. 32(5), 512\u2013518 (2004).","journal-title":"Drug Metabol. Dispos."},{"issue":"11","key":"20913_CR32","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","volume":"94","author":"J Hakkola","year":"2020","unstructured":"Hakkola, J., Hukkanen, J., Turpeinen, M. & Pelkonen, O. Inhibition and induction of CYP enzymes in humans: an update. Arch. Toxicol. 94(11), 3671\u20133722 (2020).","journal-title":"Arch. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20913-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20913-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20913-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:58:26Z","timestamp":1761127106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20913-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20913-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36905"}}